Anti-ADGRF4 monoclonal antibody

Pre-made anti-ADGRF4 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to ADGRF4/ADGRF4 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP0930-Ab-1/ GM-Tg-hg-IP0930-Ab-2Anti-Human ADGRF4 monoclonal antibodyHuman
GM-Tg-rg-IP0930-Ab-1/ GM-Tg-rg-IP0930-Ab-2Anti-Rat ADGRF4 monoclonal antibodyRat
GM-Tg-mg-IP0930-Ab-1/ GM-Tg-mg-IP0930-Ab-2Anti-Mouse ADGRF4 monoclonal antibodyMouse
GM-Tg-cynog-IP0930-Ab-1/ GM-Tg-cynog-IP0930-Ab-2Anti-Cynomolgus/ Rhesus macaque ADGRF4 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP0930-Ab-1/ GM-Tg-felg-IP0930-Ab-2Anti-Feline ADGRF4 monoclonal antibodyFeline
GM-Tg-cang-IP0930-Ab-1/ GM-Tg-cang-IP0930-Ab-2Anti-Canine ADGRF4 monoclonal antibodyCanine
GM-Tg-bovg-IP0930-Ab-1/ GM-Tg-bovg-IP0930-Ab-2Anti-Bovine ADGRF4 monoclonal antibodyBovine
GM-Tg-equg-IP0930-Ab-1/ GM-Tg-equg-IP0930-Ab-2Anti-Equine ADGRF4 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP0930-Ab-1/ GM-Tg-hg-IP0930-Ab-2; GM-Tg-rg-IP0930-Ab-1/ GM-Tg-rg-IP0930-Ab-2;
GM-Tg-mg-IP0930-Ab-1/ GM-Tg-mg-IP0930-Ab-2; GM-Tg-cynog-IP0930-Ab-1/ GM-Tg-cynog-IP0930-Ab-2;
GM-Tg-felg-IP0930-Ab-1/ GM-Tg-felg-IP0930-Ab-2; GM-Tg-cang-IP0930-Ab-1/ GM-Tg-cang-IP0930-Ab-2;
GM-Tg-bovg-IP0930-Ab-1/ GM-Tg-bovg-IP0930-Ab-2; GM-Tg-equg-IP0930-Ab-1/ GM-Tg-equg-IP0930-Ab-2
Products NameAnti-ADGRF4 monoclonal antibody
Formatmab
Target NameADGRF4
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-ADGRF4 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP0930-Ag-1Recombinant multi-species AGRF4/ ADGRF4/ GPR115 protein


    Target information

    Target IDGM-IP0930
    Target NameADGRF4
    Gene ID221393,78249,501106,100425759,481827,101092112,517950,100068555
    Gene Symbol and Synonyms4632435A09Rik,ADGRF4,GPR115,PGR18,RGD1565216
    Uniprot AccessionQ8IZF3
    Uniprot Entry NameAGRF4_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000153294
    Target ClassificationGPCR

    The target: ADGRF4, gene name: ADGRF4, also named as GPR115, PGR18. Sequence analysis of this gene suggests that it is encodes a member of the superfamily of G protein-couple receptors. G protein-coupled receptors typically contain seven hydrophobic transmembrane domains, interact with guanine nucleotide binding regulatory proteins, and detect molecules outside the cell and act to transduce these signals into intracellular responses. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2016].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.